Advertisement

PentaVision

Optometric Management

Article

LEADING OFF: Also Notable

Optometric Management July 1, 2023 Vol 58, Issue July 2023 Page(s): 16
  • Alcon and the World Council of Optometry demonstrated their “Dry Eye Wheel” tool at the 2023 BCLA Clinical Conference & Exhibition on June 10. More information can be found at bit.ly/DryEyeWheelAN .
  • The Centre for Ocular Research & Education has published an issue of “Contact Lens Update” dedicated to the successful management of ectatic corneal diseases, such as keratoconus. This bimonthly issue is available at no charge by visiting www.contactlensupdate.com .
  • New research published in Diabetic Medicine shows handheld electroretinography and optical coherence tomography angiography can identify early retinal neurovascular dysfunction, in the absence of retinopathy on fundus imaging. The study can be viewed at bit.ly/NeovascularResearchDM .
  • Eschenbach Optik has launched Eschenbach Academy, an online educational platform designed to complement the low vision knowledge and training Eschenbach currently provide in-person and via webinars. Learn more about Eschenbach Academy at bit.ly/EschenbachAcademyAN .
  • EssilorLuxottica and the United Nations Special Envoy for Road Safety have joined to promote an awareness campaign, “Check your vision – Drive Safe,” to support the United Nations road safety targets. This campaign will be rolled out across EssilorLuxottica’s business networks, in an effort to reach the widest possible audience. In other EssilorLuxottica news, the company has also teamed with World Society of Paediatric Ophthalmology and Strabismus (WSPOS) to provide WSPOS’ medical education content on myopia management via Leonardo, EssilorLuxottica’s open-learning platform.
  • Euclid Vision and Visionary Optics will host multiple specialty contact lens dinner discussions in cities around the United States. The program, “Patient Selection to Practice Growth: A Guide to Specialty Contact Lenses,” will bring eye care practitioners together to learn from industry experts and network with like-minded professionals. Learn more at bit.ly/EuclidVOlensforums .
  • Glaukos Corp. announced the completion of enrollment and randomization of its second Phase 3 confirmatory pivotal trial for Epioxa, its corneal collagen cross-linking therapy for the treatment of keratoconus. The multi-center, randomized, placebo and sham procedure-controlled confirmatory pivotal trial randomized 312 eyes to evaluate the safety and efficacy of Epioxa therapy in impeding the progression of, and/or reducing maximum corneal curvature based on corneal topography, where an increasing Kmax denotes corneal steepening and keratoconus disease progression.
  • World Sight Day, led by the International Agency for the Prevention of Blindness (IAPB), will emphasize the importance of prioritizing eye care in the workplace with the theme #LoveYourEyes at Work. World Sight Day will be celebrated Oct. 12, 2023. From employee productivity and safety, to businesses taking the necessary steps to ensure their workforce, at all levels, the theme aims to raise awareness of the measures to protect eyesight and access eye care wherever and whenever it is needed.
  • The International Sports Vision Association (ISVA) launched “Ask a Sports Vision Expert” on its website. The service has optometrists, athletic trainers, researchers, and others with expertise in sports vision assessment and training respond to questions related to how the visual system can help athletes gain optimal performance in a variety of sports and leisure activities. For more information, go to www.sportsvision.pro/ask-a-sports-vision-expert .

What to Read Next